The FDA has approved Eylea HD (aflibercept) 8 mg to treat patients with macular edema following retinal vein occlusion (RVO) with dosing of up to every 8 weeks after an initial monthly dosing period.

MIDDLETOWN, Pa. — A Dauphin County couple has been accused of medically neglecting a 13-year-old child in their care after ...

When the 13-year-old boy's doctor recommended the parents attend diabetes education, only the dad showed because the mom was ...

A new study suggests that individuals with type 2 diabetes can lower their risk of kidney disease by increasing their intake ...

Texas Tech University Health Sciences Center El Paso has been piloting a program that helps dentists identify patients who are diabetic or prediabetic to improve overall health. The dental school ...

Diabetes is one of the rapidly growing global diseases. According to the latest World Health Organization report released in ...

The nods allow Regeneron to better compete with Roche, which stormed the market in 2022 with Vabysmo. The Swiss drugmaker's ...

Sun Pharma has launched an eye-opening awareness push about a common—and commonly overlooked—complication of diabetes. | Sun Pharma has launched an eye-opening awareness push about a common—and ...

Regeneron Pharmaceuticals, Inc. REGN announced that the European Commission (EC) has approved label expansion of its PD-1 inhibitor Libtayo (cemiplimab). The EC approved Libtayo as an adjuvant ...

A tragic incident has unfolded in Santiago de Cuba, where Sheila Sinai Escobar Puente, a one-year-old girl, has sadly passed ...

FibroBiologics, Inc. (Nasdaq: FBLG) (“FibroBiologics”), a clinical-stage biotechnology company with 270+ patents issued and pending with a focus on the development of therapeutics and potential cures ...